β-blocker therapy in atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 7 II, 2003, Pages 1607-1612

  Grönefeld, Gerian C ^a   Hohnloser, Stefan H ^a,b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Antiadrenergic therapy; Antiarrhythmic drug therapy; Atrial fibrillation; Beta blocking agents; Cardioversion

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOPROLOL; CALCIUM ANTAGONIST; CELIPROLOL; DIGOXIN; DILTIAZEM; ESMOLOL; METOPROLOL; PINDOLOL; PLACEBO; PROPRANOLOL; SOTALOL; VERAPAMIL; XAMOTEROL;

ANTIARRHYTHMIC ACTIVITY; CARDIOVASCULAR DISEASE; CLINICAL MEDICINE; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; PROGNOSIS; PROSPECTIVE STUDY; REGULATORY MECHANISM; RETROSPECTIVE STUDY; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 0037626393     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.t01-1-00239.x     Document Type: Conference Paper

References (48)

1. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001; 38:1201-1213.
2. Kjeldsen SE, Erdine S, Farsang C, et al. 1999 WHO/ISH Hypertension Guidelines-highlights & ESH update. J Hypertens 2002; 20:153-55.
3. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999; 33:2092-2197.
4. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988; 260:2259-2263.
5. Hennekens CH, Albert CM, Godfried SL, et al. Adjunctive drug therapy of acute myocardial infarction-evidence from clinical trials. N Engl J Med 1996; 335:1660-1667.
6. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial. Lancet 2000; 356:1789-1794.
7. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104:2128-2150.
8. Kuhlkamp V, Schirdewan A, Stangl K, et al. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2000; 36:139-146.
9. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96:2455-2461.
10. Hohnloser SH, Woosley RL. Sotalol. N Engl J Med 1994; 331:31-38.
11. Plewan A, Lehmann G, Ndrepepa G, et al. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Eur Heart J 2001; 22:1504-1510.
12. Steeds RP, Birchall AS, Smith M, et al. An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation. Heart 1999; 82:170-175.
13. Crijns HJ, Gelder IC, Lie KI. Benefits and risks of antiarrhythmic drug therapy after DC electrical cardioversion of atrial fibrillation or flutter. Eur Heart J 1994; 15(Suppl. A):17-21.
14. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000; 342:913-920.
15. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659-666.
16. Todd DM, Fynn SP, Hobbs WJ, et al. Prevalence and significance of focal sources of atrial arrhythmia in patients undergoing cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2000; 11:616-622.
17. Maounis T, Kyrozi E, Katsaros K, et al. The prognostic significance of atrial arrhythmias recorded early after cardioversion for atrial fibrillation. PACE 2001; 24:1076-1081.
18. Hobbs WJ, Fynn S, Todd DM, et al. Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans. Circulation 2000; 101:1145-1151.
19. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996; 94:2968-2974.
20. Yu WC, Lee SH, Tai CT, et al. Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 1999; 42:470-476.
21. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999; 100:1879-1886.
22. Nattel S. Therapeutic implications of atrial fibrillation mechanisms: Can mechanistic insights be used to improve AF management? Cardiovasc Res 2002; 54:347-360.
23. Wyse DG, Waldo AZ, DiMarco JP, et al A companison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825-1833.
24. Falk RH, Knowlton AA, Bernard SA, et al. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med 1987; 106:503-506.
25. Ellenbogen KA, Dias VC, Plumb VJ, et al. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter study. J Am Coll Cardiol 1991; 18:891-897.
26. Rinkenberger RL, Prystowsky EN, Heger JJ, et al. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation 1980; 62:996-1010.
27. Wiest D. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics. Clin Pharmacokinet 1995; 28:190-202.
28. Platia EV, Michelsen EL, Porterfield JK, et al. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 1989; 63:925-929.
29. Hohnloser SH, Meinertz T, Klingenheben T, et al. Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group. Am J Cardiol 1991; 67:1319-1323.
30. Gray RJ. Bateman TM, Czer LS, et al. Esmolol: A new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. J Am Coll Cardiol 1985: 5:1451-1456.
31. Shettigar UR, Toole JG, Appunn DO. Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter. Am Heart J 1993; 126:368-374.
32. Atwood JE, Sullivan M, Forbes S, et al. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. J Am Coll Cardiol 1987; 10:314-320.
33. James MA, Channer KS, Papouchado M, et al. Improved control of atrial fibrillation with combined pindolol and digoxin therapy. Eur Heart J 1989; 10:83-90.
34. Koh KK, Song JH, Kwon KS, et al. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digexin to control ventricular rate in chronic atrial fibrillation: Randomized crossover study. Int J Cardiol 1995; 52:167-174.
35. Lewis RV, McMurray J, McDevitt DG. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. J Cardiovasc Pharmacol 1989; 13:1-6.
36. Farshi R, Kistner D, Sarma JS, et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: A crossover open-label study of five drug regimens. J Am Coll Cardiol 1999; 33:304-310.
37. Ehrlich JR, Nattel S, Hohnloser SH. Atrial fibrillation and congestive heart failure: Specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol 2002; 13:399-405.
38. Australia-New Zealand Heart Failure Research Collaborative Group. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 1995; 92:212-218.
39. The Cardiac Insufficiency Biseprolol Study II (CIBIS-II): A randemised trial. Lancet 1999; 353:9-13.
40. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353:2001-2007.
41. Lechat P, Hulot JS, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001; 103:1428-1433.
42. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996; 94:390-397.
43. Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A rectaanalysis of randomized control trials. Circulation 1991; 84:III236-III244.
44. Hogue CW Jr, Hyder ML. Atrial fibrillation after cardiac operation: Risks, mechanisms, and treatment. Ann Thorac Surg 2000; 69:300-306.
45. Place DG, Peragallo RA, Carroll J, et al. Postoperative atrial fibrillation: A comparison of off-pump coronary artery bypass surgery and conventional coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2002; 16:144-148.
46. Angelini GD, Taylor FC, Reeves BC, et al. Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): A pooled analysis of two randomised controlled trials. Lancet 2002; 359:1194-1199.
47. Crystal E, Connolly S, Sleik K, et al. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery. A meta-analysis. Circulation 2002; 104e:CIR.0000021113.44111.3E.
48. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135:1061-1073.